BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25093848)

  • 1. Serum miRNA signature in Moyamoya disease.
    Dai D; Lu Q; Huang Q; Yang P; Hong B; Xu Y; Zhao W; Liu J; Li Q
    PLoS One; 2014; 9(8):e102382. PubMed ID: 25093848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line.
    Uchino H; Ito M; Kazumata K; Hama Y; Hamauchi S; Terasaka S; Sasaki H; Houkin K
    BMC Med Genomics; 2018 Aug; 11(1):72. PubMed ID: 30157848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis.
    Fujimura M; Fujimura T; Kakizaki A; Sato-Maeda M; Niizuma K; Tomata Y; Aiba S; Tominaga T
    Brain Res; 2018 Jan; 1679():39-44. PubMed ID: 29174692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exosomal microRNAs are non-invasive biomarkers of moyamoya disease: A pilot study.
    Huang D; Qi H; Yang H; Chen M
    Clinics (Sao Paulo); 2023; 78():100247. PubMed ID: 37413774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Expression in Circulating Leukocytes and Bioinformatic Analysis of Patients With Moyamoya Disease.
    Kang K; Shen Y; Zhang Q; Lu J; Ju Y; Ji R; Li N; Wu J; Yang B; Lin J; Liang X; Zhang D; Zhao X
    Front Genet; 2022; 13():816919. PubMed ID: 35669195
    [No Abstract]   [Full Text] [Related]  

  • 6. Circular RNA profiling of neutrophil transcriptome provides insights into asymptomatic Moyamoya disease.
    Ma Q; Li L; Yu B; Jiao L; Han Z; Zhao H; Li G; Ma Y; Luo Y
    Brain Res; 2019 Sep; 1719():104-112. PubMed ID: 31132337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
    Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cav-1 (Caveolin-1) and Arterial Remodeling in Adult Moyamoya Disease.
    Chung JW; Kim DH; Oh MJ; Cho YH; Kim EH; Moon GJ; Ki CS; Cha J; Kim KH; Jeon P; Yeon JY; Kim GM; Kim JS; Hong SC; Bang OY
    Stroke; 2018 Nov; 49(11):2597-2604. PubMed ID: 30355208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
    Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNF213 rare variants in an ethnically diverse population with Moyamoya disease.
    Cecchi AC; Guo D; Ren Z; Flynn K; Santos-Cortez RL; Leal SM; Wang GT; Regalado ES; Steinberg GK; Shendure J; Bamshad MJ; ; Grotta JC; Nickerson DA; Pannu H; Milewicz DM
    Stroke; 2014 Nov; 45(11):3200-7. PubMed ID: 25278557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis of transfer RNA‑derived fragments in the blood of patients with moyamoya disease: A preliminary study.
    Wang C; Zhao M; Wang J; Zhang D; Wang S; Zhao J
    Mol Med Rep; 2019 May; 19(5):3564-3574. PubMed ID: 30896793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis.
    Huang Y; Cheng D; Zhang J; Zhao W
    J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
    Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
    Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
    Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
    PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircZXDC Promotes Vascular Smooth Muscle Cell Transdifferentiation via Regulating miRNA-125a-3p/ABCC6 in Moyamoya Disease.
    Liu Y; Huang Y; Zhang X; Ma X; He X; Gan C; Zou X; Wang S; Shu K; Lei T; Zhang H
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.
    Kanoke A; Fujimura M; Niizuma K; Ito A; Sakata H; Sato-Maeda M; Morita-Fujimura Y; Kure S; Tominaga T
    Brain Res; 2015 Oct; 1624():497-505. PubMed ID: 26315378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NFκB activation and apoptosis in an AAA+ domain-dependent manner.
    Takeda M; Tezuka T; Kim M; Choi J; Oichi Y; Kobayashi H; Harada KH; Mizushima T; Taketani S; Koizumi A; Youssefian S
    Biochem Biophys Res Commun; 2020 May; 525(3):668-674. PubMed ID: 32139119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
    Duan L; Wei L; Tian Y; Zhang Z; Hu P; Wei Q; Liu S; Zhang J; Wang Y; Li D; Yang W; Zong R; Xian P; Han C; Bao X; Zhao F; Feng J; Liu W; Cao W; Zhou G; Zhu C; Yu F; Yang W; Meng Y; Wang J; Chen X; Wang Y; Shen B; Zhao B; Wan J; Zhang F; Zhao G; Xu A; Zhang X; Liu J; Zuo X; Wang K
    Stroke; 2018 Jan; 49(1):11-18. PubMed ID: 29273593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.